{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:24:28Z","timestamp":1790706268016,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":3314,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1111\/ajt.12437","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T13:12:01Z","timestamp":1378386721000},"page":"2902-2911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of Calcineurin-Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone-Free Regimen"],"prefix":"10.1016","volume":"13","author":[{"given":"D.","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Leventhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sustento-Reodica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Najafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.12437_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-6143.2004.00332.x","article-title":"Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/ki.1991.206","article-title":"Nature and extent of glomerular injury induced by cyclosporine in heart-transplant patients","volume":"40","author":"Bertani","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12437_bib3","doi-asserted-by":"crossref","first-page":"SS11","DOI":"10.1097\/00007890-200006271-00003","article-title":"Histopathology of calcineurin inhibitor-induced nephrotoxicity","volume":"69","author":"Davies","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib4","first-page":"515","article-title":"Insights into chronic cyclosporine nephrotoxicity","volume":"34","author":"Bennett","year":"1996","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/ajt.12437_bib5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0167-5699(98)01324-3","article-title":"Chronic rejection and chronic cyclosporin toxicity in renal allografts","volume":"19","author":"Pascual","year":"1998","journal-title":"Immunol Today"},{"key":"10.1111\/ajt.12437_bib6","first-page":"S70","article-title":"Cyclosporine-induced renal dysfunction in experimental-animals and humans","volume":"48","author":"Remuzzi","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12437_bib7","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/00007890-199812270-00029","article-title":"Histopathologic findings from 2-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group","volume":"66","author":"Solez","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib8","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12437_bib9","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1097\/01.ASN.0000095250.92361.D5","article-title":"Long-term graft survival with neoral and tacrolimus: A paired kidney analysis","volume":"14","author":"Kaplan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12437_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1600-6143.2010.03312.x","article-title":"The histology of solitary renal allografts at 1 and 5 years after transplantation","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity\u2014lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-6143.2011.03505.x","article-title":"Chronic progressive calcineurin nephrotoxicity: An overstated concept","volume":"11","author":"Matas","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib13","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1600-6143.2011.03718.x","article-title":"Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy","volume":"11","author":"Snanoudj","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-6143.2009.02954.x","article-title":"Pathological and clinical characterization of the \u2018troubled transplant\u2019: Data from the DeKAF study","volume":"10","author":"Gourishankar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5001644","article-title":"The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?","volume":"70","author":"Knight","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12437_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":"Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus","volume":"6","author":"Larson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/TP.0b013e31816a8ae6","article-title":"Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus","volume":"85","author":"Dean","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.tp.0000258586.52777.4c","article-title":"Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs","volume":"83","author":"Flechner","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: A randomized, controlled Spare-the-Nephron trial","volume":"79","author":"Weir","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.12437_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","article-title":"Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: Concept study","volume":"9","author":"Lebranchu","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(10)62318-5","article-title":"Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: An open-label, randomised, controlled trial","volume":"377","author":"Budde","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/ajt.12437_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2215\/CJN.00790306","article-title":"Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function","volume":"1","author":"Gallon","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1111\/ajt.12437_bib25","first-page":"208","article-title":"Steroid avoidance and delayed introduction of tacrolimus using alemtuzumab induction in kidney transplantation: Five year follow-up","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib27","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1600-6143.2004.00579.x","article-title":"Performance of different prediction equations for estimating renal function in kidney transplantation","volume":"4","author":"Gaspari","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"Br Med J"},{"key":"10.1111\/ajt.12437_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201905 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs: A prospective, randomized trial of sirolimus versus cyclosporine","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib31","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1681\/ASN.2007091001","article-title":"Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients","volume":"19","author":"Hamdy","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12437_bib33","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.TP.0000121504.69676.5E","article-title":"Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation","volume":"77","author":"Lo","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib34","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12437_bib35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1600-6143.2011.03573.x","article-title":"The ORION study: Comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients","volume":"11","author":"Flechner","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib36","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/TP.0b013e3181e11798","article-title":"Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: One-year analysis of a randomized multicenter trial","volume":"90","author":"Guba","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib38","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/j.1600-6143.2012.04162.x","article-title":"Improved renal function after early conversion from a calcineurin inhibitor to everolimus: A randomized trial in kidney transplantation","volume":"12","author":"Mj\u00f6rnstedt","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib39","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1600-6143.2012.03994.x","article-title":"Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study","volume":"12","author":"Budde","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1432-2277.2012.01432.x","article-title":"Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: Observational results at 24 and 36 months after transplantation","volume":"25","author":"Guba","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.12437_bib41","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","article-title":"Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study","volume":"11","author":"Lebranchu","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/TP.0b013e31822805d7","article-title":"Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal","volume":"92","author":"Heilman","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e318224c12d","article-title":"Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: A randomized, multicenter, 24-month study","volume":"92","author":"Holdaas","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib45","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/01.tp.0000237101.58974.43","article-title":"Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: A systematic review of the evidence","volume":"82","author":"Mulay","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-0012.2004.00235.x","article-title":"Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up","volume":"18","author":"Aakhus","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.12437_bib47","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1600-6143.2008.02328.x","article-title":"Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period","volume":"8","author":"Luan","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib48","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1111\/j.1523-1755.2004.09213.x","article-title":"Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: A case for albuminuria","author":"Anavekar","year":"2004","journal-title":"Kidney Int Suppl"},{"key":"10.1111\/ajt.12437_bib49","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.ATV.19.8.1992","article-title":"Urinary albumin excretion. An independent predictor of ischemic heart disease","volume":"19","author":"Borch-Johnsen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/ajt.12437_bib50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007890-200108150-00014","article-title":"Proteinuria after renal transplantation affects not only graft survival but also patient survival","volume":"72","author":"Roodnat","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib51","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1600-6143.2007.02142.x","article-title":"Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients","volume":"8","author":"Aliabadi","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib52","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/ndt\/gfm181","article-title":"Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: Comparison of two CNI-free protocols","volume":"22","author":"Diekmann","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.12437_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.transproceed.2007.01.038","article-title":"Proteinuria in transplant patients associated with sirolimus","volume":"39","author":"Franco","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.12437_bib54","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/01.tp.0000282866.92367.99","article-title":"The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat","volume":"84","author":"Vogelbacher","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-6143.2012.04334.x","article-title":"The effect of everolimus versus mycophenolate upon proteinuria following kidney transplant and relationship to graft outcomes","volume":"13","author":"Wiseman","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.12437_bib56","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.12437_bib57","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12437_bib58","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12437","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522261875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522261875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:03:23Z","timestamp":1761627803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522261875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1600613522261875"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12437","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Calcineurin-Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone-Free Regimen","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}